SORT1 and ovarian carcinoma: Further research into the ectopic expression of SORT1 in ovarian carcinoma has shown a four-fold increase in its gene expression in carcinoma tissues compared to non-malignant tissues, highlighting its absence in normal ovarian tissue and its potential as a novel tumor marker.